title: Activated naive CD4+ peripheral blood T cells in autoimmune thyroid disease.
abstract: To better understand the clinical significance of changes in lymphocytes in thyroid disease this study analyzed the proportion of CD19+, CD3+, CD4+ and CD8+ cells among circulating lymphocytes in Graves' disease (GD, n = 34) and autoimmune hypothyroidism (AH, n = 28) vs healthy subjects (n = 15). In addition, the expression of CD25 and CD45 isoforms on CD4+ T cells as well as their modulation by methimazole in patients with GD was measured using three color flow cytometry. It was observed that, irrespective of age, both patients with GD (17.6 +/- 7.0% +/- SD) and those with AH (19.0 +/- 9.5%) had an increased percentage of the CD25+CD45RA+ (naive) subpopulation of helper cells vs healthy subjects (7.9 +/- 2.3%, p < 0.0001). In patients with AH peripheral memory cells and hence overall CD25+ cells were more frequent among helper cells (56.7 +/- 12.2%) than in healthy subjects (40.8 +/- 14.0%, p < 0.001). Patients with GD (46.2 +/- 13.4%) did not differ from normal subjects in this respect. Treatment of GD with MMI reduced the percentage of CD25+CD45RA+ cells among CD4+ cells toward values seen in healthy subjects. In addition, we confirm previous reports that CD8+ cells toward values seen in healthy subjects. In addition, we confirm previous reports that CD8+ cells are significantly reduced in AH (23.9 +/- 4.9%) and untreated Graves' disease (23.2 +/- 6.6%) vs healthy subjects (32.2 +/- 5.9%, p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Division of Endocrinology and Metabolism, University of Vienna, Austria.
authors.forename: A
authors.initials: A
authors.lastname: Gessl
authors.forename: A
authors.initials: A
authors.lastname: Wilfing
authors.forename: H
authors.initials: H
authors.lastname: Agis
authors.forename: G
authors.initials: G
authors.lastname: Steiner
authors.forename: S
authors.initials: S
authors.lastname: Czernin
authors.forename: G
authors.initials: G
authors.lastname: Boltz-Nitulescu
authors.forename: H
authors.initials: H
authors.lastname: Vierhapper
authors.forename: W
authors.initials: W
authors.lastname: Waldhäusl
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000502:physiology*; D005260:Female; D005434:Flow Cytometry; D006111:Graves Disease / Q000097:blood / Q000188:drug therapy; D006801:Humans; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D016176:T-Lymphocyte Subsets / Q000502:physiology; D013967:Thyroiditis, Autoimmune / Q000188:drug therapy / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D008713:Methimazole